Marten Beeg

Via Mario Negri, 2
Milan, 20156, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 38 publications

Development of a portable device for the detection of anti-PEG antibodies in human plasma.

Development of a portable device for the detection of anti-PEG antibodies in human plasma.

Journal: Scientific reports

Published: April 21, 2026

Tau catalyzes amyloid-β aggregation and toxicity in a polymorph-dependent manner.

Tau catalyzes amyloid-β aggregation and toxicity in a polymorph-dependent manner.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: March 25, 2026

Integrating Surface Plasmon Resonance and Docking Analysis for Mechanistic Insights of Tryptase Inhibitors.

Integrating Surface Plasmon Resonance and Docking Analysis for Mechanistic Insights of Tryptase Inhibitors.

Journal: Molecules (Basel, Switzerland)

Published: February 12, 2025

The Detection of Toxic Amyloid-β Fibril Fragments Through a Surface Plasmon Resonance Immunoassay.

The Detection of Toxic Amyloid-β Fibril Fragments Through a Surface Plasmon Resonance Immunoassay.

Journal: International journal of molecular sciences

Published: November 06, 2024

Tau oligomers impair memory and synaptic plasticity through the cellular prion protein.

Tau oligomers impair memory and synaptic plasticity through the cellular prion protein.

Journal: Acta neuropathologica communications

Published: October 23, 2024

Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.

Small molecule-mediated inhibition of the oxidoreductase ERO1A restrains aggressive breast cancer by impairing VEGF and PD-L1 in the tumor microenvironment.

Journal: Cell death & disease

Published: September 18, 2024

Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors.

Artificial Intelligence-Powered Molecular Docking and Steered Molecular Dynamics for Accurate scFv Selection of Anti-CD30 Chimeric Antigen Receptors.

Journal: International journal of molecular sciences

Published: June 12, 2024

Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1.

Development of a Bispecific IgG1 Antibody Targeting BCMA and PDL1.

Journal: Antibodies (Basel, Switzerland)

Published: December 07, 2023

A Comprehensive Technology Platform for the Rapid Discovery of Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection.

A Comprehensive Technology Platform for the Rapid Discovery of Peptide Inhibitors against SARS-CoV-2 Pseudovirus Infection.

Journal: International journal of molecular sciences

Published: June 08, 2023

Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity.

Amyposomes, a nanotechnological chaperone with anti-amyloidogenic activity.

Journal: Annals of medicine

Published: May 05, 2023

Anti-emicizumab antibodies do not cross-react with mim8 in vitro.

Anti-emicizumab antibodies do not cross-react with mim8 in vitro.

Journal: Research and practice in thrombosis and haemostasis

Published: April 11, 2023

Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury.

Aβ1-6A2V(D) peptide, effective on Aβ aggregation, inhibits tau misfolding and protects the brain after traumatic brain injury.

Journal: Molecular psychiatry

Published: January 10, 2023

Showing 1-12 of 38

Last Updated: 09/26/2026